Related Experiment Video
Updated: Aug 5, 2026

Establishment of a High-throughput Setup for Screening Small Molecules That Modulate c-di-GMP Signaling in Pseudomonas aeruginosa
Published on: June 30, 2016
The Cyclic Di-GMP Receptor HpoR Modulates Mycobacterial Multidrug Susceptibility by Regulating IniBAC-Mediated
Xiao Liu1,2, Xiaocui Ling1,2, Kun Wang1
1State Key Laboratory for Conservation and Utilization of Subtropical Agro-Bioresources, Guangxi Technology Innovation Center for Microbial Resources Development and Utilization, College of Life Science and Technology, Guangxi University, Nanning 530004, China.
Cyclic di-GMP (c-di-GMP) reduces isoniazid (INH) susceptibility by interacting with the HpoR receptor. This interaction modulates the iniBAC operon, decreasing envelope permeability and INH resistance in mycobacteria.
Area of Science:
- Microbiology
- Molecular Biology
- Drug Discovery
Background:
- Isoniazid (INH) is a key antimycobacterial drug targeting cell wall biosynthesis.
- Understanding drug resistance mechanisms, particularly INH tolerance, is crucial for combating pathogenic mycobacteria.
- The iniBAC operon is known to influence INH tolerance and envelope permeability, but its transcriptional regulation under INH stress is not fully understood.
Purpose of the Study:
- To investigate the role of the second messenger cyclic di-GMP (c-di-GMP) in modulating INH susceptibility in mycobacteria.
- To identify the downstream receptor(s) and regulatory pathways of c-di-GMP in mycobacterial drug response.
- To elucidate the mechanism by which c-di-GMP affects the iniBAC operon and subsequent drug susceptibility.
Main Methods:
- Investigated the effect of c-di-GMP on INH susceptibility in *M. bovis* BCG and *M. smegmatis*.
- Identified HpoR as the c-di-GMP receptor involved in INH tolerance.
- Analyzed the transcriptional regulation of the iniBAC operon by c-di-GMP and HpoR using concentration-dependent assays.
Main Results:
- Demonstrated that c-di-GMP significantly reduces INH susceptibility in mycobacteria.
- Showed that c-di-GMP acts through the receptor HpoR to alleviate repression of the iniBAC operon.
- Observed a concentration-dependent decrease in envelope permeability and modulation of multidrug susceptibility due to c-di-GMP/HpoR interaction.
Conclusions:
- c-di-GMP, via the HpoR receptor, plays a critical role in regulating INH susceptibility in mycobacteria.
- The c-di-GMP-HpoR-iniBAC regulatory axis offers a novel target for understanding and potentially overcoming INH resistance.
- This regulatory mechanism is likely conserved across pathogenic mycobacterial species, highlighting its importance in intrinsic drug resistance.
More Related Videos
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Two...
Inhibitors of Gram-positive Cell Wall Synthesis
GPCR Desensitization
IP3/DAG Signaling Pathway
Activation and Inactivation of G Proteins
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...

